CSIMarket
 

Senti Biosciences Inc   (SNTI)
Other Ticker:  
 

Senti Biosciences Inc 's Working Capital Per Sales

SNTI's Working Capital and Revenue growth



SNTI Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -33.71 % -57.92 % - 5429.03 % 5599.51 %
Y / Y Revenue Change -80.86 % -31 % - - -
Working Capital Per Revenue 18.41 15 17.15 18.23 18.37
Total Ranking # 3027 # 3064 # 2167 # 0 # 0
Seq. Working Capital Change 29.83 % -21.55 % -19.97 % -18.67 % -17.6 %
Seq. Revenue Change -63.93 % -27.14 % 10.67 % -34.2 % 30.04 %





Comment on SNTI's Working Capital Per Revenue in the third quarter 2023
Senti Biosciences Inc 's Working Capital Per Revenue sequentially grew to 18.41 during the Q3 2023, a new company high. Due to increase of revenue in the Q3 2023 year on year by -80.86%.

Within Healthcare sector 146 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Senti Biosciences Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 3027, from total ranking in the second quarter 2023 at 3064.
Working Capital Per Revenue Ranking
Within: No.
Industry # 12
Sector # 147
S&P 500 # 3027


Working Capital Per Revenue Statistics
High Average Low
18.41
16.85
15
(Sep 30 2023)   (Jun 30 2023)



Financial Statements
Senti Biosciences Inc 's Working Capital $ 69 Millions Visit SNTI's Balance sheet
Senti Biosciences Inc 's Revenues $ 0 Millions Visit SNTI's Income Statement
Where are SNTI's Sales coming from? Visit SNTI's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Talis Biomedical Corporation  45.40 
Bridgebio Pharma Inc   44.76 
Astrotech Corp  38.12 
Janux Therapeutics Inc   37.01 
Omega Therapeutics Inc   36.33 
Clene Inc   35.55 
Relay Therapeutics Inc   33.63 
Lumos Pharma Inc   30.84 
Cardiff Oncology inc   29.95 
Agios Pharmaceuticals Inc   29.80 
Enzon Pharmaceuticals inc   27.93 
Anaptysbio Inc   26.88 
Bioaffinity Technologies Inc   24.93 
Stoke Therapeutics Inc   23.81 
Seer Inc   22.23 
Mirati Therapeutics Inc   21.88 
Catheter Precision Inc   21.63 
Ambrx Biopharma Inc   19.17 
Absci Corp  18.88 
Inovio Pharmaceuticals Inc   18.76 
Senti Biosciences Inc   18.41 
Verrica Pharmaceuticals Inc   17.75 
Intellia Therapeutics Inc   17.35 
Ideaya Biosciences Inc   16.89 
Bolt Biotherapeutics Inc   16.84 
Abcellera Biologics Inc   16.77 
Co diagnostics Inc   16.62 
Miromatrix Medical inc   16.11 
Syros Pharmaceuticals Inc   15.61 
Clearside Biomedical Inc   15.49 
Date modified: 2023-11-17T09:48:39+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com